Expertise in
9
conditions

Martin Metz

Berlin, BE, DE 
Expertise in
9
conditions
Berlin, BE, DE 

Overview

Martin Metz practices practicing medicine in Berlin, Germany.

Mr. Metz is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Chronic Spontaneous Urticaria (CSU), Hives, Prurigo Nodularis, and Cold Urticaria.

He is actively involved in clinical research, co-authoring 271 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Berlin, BE, Germany
Other Locations
Muenster, NW 48149, Germany
Bochum, NW 44791, Germany
Hannover, NI, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Proof of Concept, Multicenter, 16-week Treatment Study With a 16 Week Follow-up Period to Assess the Efficacy and Safety of Dupilumab (Anti-IL4Ra) in Adult Patients With Cholinergic Urticaria Despite H1-antihistamine Treatment
A Randomized, Double-blind, Placebo-controlled, Proof of Concept, Multicenter, 16-week Treatment Study With a 16 Week Follow-up Period to Assess the Efficacy and Safety of Dupilumab (Anti-IL4Ra) in Adult Patients With Cholinergic Urticaria Despite H1-antihistamine Treatment
Enrollment Status: Completed
Publish Date: September 06, 2023
Intervention Type: Drug
Study Drug: Dupilumab
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Single Dose Study to Assess the Safety, Pharmacokinetics, and Clinical Effect of CDX-0159 in Patients With Prurigo Nodularis
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Single Dose Study to Assess the Safety, Pharmacokinetics, and Clinical Effect of CDX-0159 in Patients With Prurigo Nodularis
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Drug, Biological
Study Drug: CDX-0159
Study Phase: Phase 1
View 1 Less Clinical Trial

271 Total Publications

Cold urticaria with negative standard cold stimulation testing: Results from the COLD-CE study.
Cold urticaria with negative standard cold stimulation testing: Results from the COLD-CE study.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 22, 2026

Frequently Asked Questions about Martin Metz

Is Martin Metz a top-rated expert for Chronic Spontaneous Urticaria (CSU)?

MediFind is an objective health platform that identifies experts based on real-world data. Martin Metz is classified as an Elite expert for Chronic Spontaneous Urticaria (CSU), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin Metz participate in research or clinical trials?

Yes. Martin Metz has published 271 articles and abstracts on conditions like Chronic Spontaneous Urticaria (CSU). You can view a list of Martin Metz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Metz's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile